Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-seq analysis for core 3' processing factors in control and U1 AMO-treated HeLa cells

ABSTRACT: To understand the effect of U1 AMO treatment on chromatin binding profiles of core 3' processing factors, we carried out ChIP-seq analysis for several core 3' processing factors after control and U1 AMO treatment

ORGANISM(S): Homo sapiens

PROVIDER: GSE193202 | GEO | 2023/02/27

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

wdr33 iCLIP-seq in control and U1 AMO-treated HeLa cells

Project description:To understand the effect of U1 AMO treatment on wdr33 binding profile , we carried out CstF64 iCLIP-seq experiments in HeLa cells treated with either control or U1 AMO.

2023-02-27 | GSE193370 | GEO

CstF64 iCLIP-seq in control and U1 AMO-treated HeLa cells

Project description:To understand the effect of U1 AMO treatment on CstF64 binding profile , we carried out CstF64 iCLIP-seq experiments in HeLa cells treated with either control or U1 AMO.

2023-02-27 | GSE192893 | GEO

ChIP-seq analysis for core 3' processing factors in control and U1 AMO-treated HeLa cells

Project description:ChIP-seq analysis for core 3' processing factors in control and U1 AMO-treated HeLa cells

| PRJNA795423 | ENA

ribo-seq in control and U1 AMO treated HeLa cells

Project description:Control and U1 AMO were transfected into Hela cells, Ribosome-associated RNAs were purified and sequenced in Novaseq platform.To compare the translation efficiency, mRNA-seq were performed in parallel.

2023-02-27 | GSE193200 | GEO

mRNA polyadenylation profile analysis in control and U1 AMO treated HeLa cells

Project description:To globally assess the effect of polyadenylation site (PAS) usage upon functional knockdown of U1 snRNP, we carried out PAS-seq analysis with control and U1 AMO-treated HeLa cells using the QuantSeq Rev 3' mRNA sequencing library prep kit (Cat. 016-24).

2019-01-22 | GSE125397 | GEO

poly(A+) RNAs 3'-seq analysis in the cytoplasmic RNAs of control and U1 AMO treated Hela cells

Project description:To understand if U1-AMO induced truncated forms of mRNAs could be exported into cytoplasm, we performed 3'-seq analysis in the cytoplasmic RNAs of control and U1 AMO treated Hela cells

2023-02-27 | GSE192894 | GEO

U1 snRNP complex with cleavage and polyadenylation factors controls mRNA transcription termination

Project description:Full-length transcription in the majority of human genes depends on U1 snRNP (U1) to co-transcriptionally suppress transcription-terminating premature 3’-end cleavage and polyadenylation (PCPA) from cryptic polyadenylation signals (PASs) in introns. However, the mechanism of this U1 activity, termed telescripting, is unknown. Here, we captured a complex, comprising U1 and CPA factors (U1–CPAFs), that binds intronic PASs and suppresses PCPA. U1–CPAFs are distinct from U1-spliceosomal complexes; they include CPA’s three main subunits, CFIm, CPSF, and CstF, lack essential splicing factors, and associate with transcription elongation and mRNA export complexes. Telescripting requires U1:pre-mRNA base-pairing, which can be disrupted by U1 antisense oligonucleotide (U1 AMO), triggering PCPA. U1 AMO remodels U1–CPAFs, revealing changes, including recruitment of CPA-stimulating factors, that explain U1–CPAFs’ switch from repressive to activated states. Our findings outline U1 telescripting mechanism and demonstrate U1’s unique role as central-regulator of pre-mRNA processing and transcription.

2019-07-31 | GSE135140 | GEO

ribo-seq in control and U1 AMO treated HeLa cells

Project description:ribo-seq in control and U1 AMO treated HeLa cells

| PRJNA795419 | ENA

CstF64 iCLIP-seq in control and U1 AMO-treated HeLa cells

Project description:CstF64 iCLIP-seq in control and U1 AMO-treated HeLa cells

| PRJNA793685 | ENA

wdr33 iCLIP-seq in control and U1 AMO-treated HeLa cells

Project description:wdr33 iCLIP-seq in control and U1 AMO-treated HeLa cells

| PRJNA795973 | ENA